Drug Shortage Report for MEROPENEM FOR INJECTION

Last updated on 2025-01-13 History
Report ID 245847
Drug Identification Number 02378795
Brand name MEROPENEM FOR INJECTION
Common or Proper name MEROPENEM FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) MEROPENEM
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10PSOIJ
ATC code J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-12-16
Estimated end date 2025-01-10
Actual end date 2025-01-13
Shortage status Resolved
Updated date 2025-01-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-01-13 French Compare
v5 2025-01-13 English Compare
v4 2024-12-17 English Compare
v3 2024-12-16 French Compare
v2 2024-12-16 English Compare
v1 2024-12-16 English Compare

Showing 1 to 6 of 6